Academic Journal

Framework nucleic Acid-MicroRNA mediated hepatic differentiation and functional hepatic spheroid development for treating acute liver failure

التفاصيل البيبلوغرافية
العنوان: Framework nucleic Acid-MicroRNA mediated hepatic differentiation and functional hepatic spheroid development for treating acute liver failure
المؤلفون: Hongyan Wei, Tiantian Xue, Fenfang Li, Enguo Ju, Haixia Wang, Mingqiang Li, Yu Tao
المصدر: Bioactive Materials, Vol 41, Iss , Pp 611-626 (2024)
بيانات النشر: KeAi Communications Co., Ltd., 2024.
سنة النشر: 2024
المجموعة: LCC:Materials of engineering and construction. Mechanics of materials
LCC:Biology (General)
مصطلحات موضوعية: Hepatic differentiation, Framework nucleic acid, Functional hepatic spheroids, Transcriptome sequencing analysis, Acute liver failure therapy, Materials of engineering and construction. Mechanics of materials, TA401-492, Biology (General), QH301-705.5
الوصف: The specific induction of hepatic differentiation presents a significant challenge in developing alternative liver cell sources and viable strategies for clinical therapy of acute liver failure (ALF). The past decade has witnessed the blossom of microRNAs in regenerative medicine. Herein, microRNA 122-functionalized tetrahedral framework nucleic acid (FNA-miR-122) has emerged as an unprecedented and potential platform for directing the hepatic differentiation of adipose-derived mesenchymal stem cells (ADMSCs), which offers a straightforward and cost-effective method for generating functional hepatocyte-like cells (FNA-miR-122-iHep). Additionally, we have successfully established a liver organoid synthesis strategy by optimizing the co-culture of FNA-miR-122-iHep with endothelial cells (HUVECs), resulting in functional Hep:HUE-liver spheroids. Transcriptome analysis not only uncovered the potential molecular mechanisms through which miR-122 influences hepatic differentiation in ADMSCs, but also clarified that Hep:HUE-liver spheroids could further facilitate hepatocyte maturation and improved tissue-specific functions, which may provide new hints to be used to develop a hepatic organoid platform. Notably, compared to transplanted ADMSCs and Hep-liver spheroid, respectively, both FNA-miR-122-iHep-based single cell therapy and Hep:HUE-liver spheroid-based therapy showed high efficacy in treating ALF in vivo. Collectively, this research establishes a robust system using microRNA to induce ADMSCs into functional hepatocyte-like cells and to generate hepatic organoids in vitro, promising a highly efficient therapeutic approach for ALF.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2452-199X
Relation: http://www.sciencedirect.com/science/article/pii/S2452199X24003608; https://doaj.org/toc/2452-199X
DOI: 10.1016/j.bioactmat.2024.08.022
URL الوصول: https://doaj.org/article/1bee14913dbf4b5ea0e41ff8de8bda5f
رقم الانضمام: edsdoj.1bee14913dbf4b5ea0e41ff8de8bda5f
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:2452199X
DOI:10.1016/j.bioactmat.2024.08.022